Cordyceps for Health & Longevity - Quick Reference Sheet

Cordyceps for Health & Longevity

Created on 07/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A well-tolerated fungal supplement with a modest, uncertain benefit ceiling. The most credible human evidence shows small, inconsistent gains in aerobic capacity, mainly in older or less-trained people, plus signals of immune and kidney support drawn from patients. Energy and healthy-aging claims rest largely on lab and animal work. Best as an add-on to training. (Full Review)

Protocol

Dose
1,000–3,000 mg/day
Concentrated extract; fermented Cs-4 studied at 1,000–3,000 mg/day
Schedule
Split 2–3× daily
Short cordycepin half-life favors divided over single dosing
Timing
Morning or pre-exercise
Energizing reputation makes late-evening dosing less preferred
Time to effect
Endurance & Energy
Several weeks
Main human trials ran 6–12 weeks; not acute
[time_2_label]
[time_2_value]
[time_2_sub]
[time_3_label]
[time_3_value]
[time_3_sub]

Benefits

Contraindications
  • Autoimmune disease
  • Active bleeding disorders
  • Upcoming surgery (stop ≥1–2 weeks prior)
  • Transplant recipients
  • Poorly controlled diabetes on glucose-lowering drugs
  • Pregnancy or breastfeeding
Key Interactions
  • Anticoagulants & antiplatelets (warfarin, apixaban, rivaroxaban, aspirin, clopidogrel)
  • Antidiabetic medications (insulin, metformin, sulfonylureas)
  • Immunosuppressants (cyclosporine, tacrolimus)
  • Immune-active supplements (echinacea, reishi, turkey tail, beta-glucans)
  • NSAIDs & fish oil (ibuprofen, naproxen)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Heavy metal & adulterant contamination
  • Low: Gastrointestinal discomfort; Additive bleeding & glucose-lowering effects; Immune overstimulation in autoimmune disease
  • Speculative: Allergic & hypersensitivity reactions; Organ effects at very high doses

Monitoring

Marker Target Why
Fasting glucose 4.4–5.0 mmol/L (79–90 mg/dL) Detects additive glucose lowering
Hemoglobin A1c < 5.4% Tracks average blood sugar over months
eGFR / serum creatinine eGFR > 90 mL/min/1.73 m² Baseline kidney filtration; relevant to kidney-support claims
Blood urea nitrogen (BUN) 10–16 mg/dL Kidney waste-clearance marker
hs-CRP < 1.0 mg/L Gauges baseline inflammation and any change
ALT / AST ALT < 25 U/L; AST < 25 U/L Screens for liver stress during use
Platelet count / coagulation Platelets 150–400 ×10⁹/L; INR in target if on warfarin Watches additive bleeding risk

Cadence: Recheck at 8–12 weeks after starting, then every 6–12 months (more often if using diabetes or anticoagulant medication)

Qualitative Assessment

  • Energy levels and perceived fatigue during the day
  • Endurance and recovery in training sessions
  • Frequency of minor infections or illness
  • Sleep quality (watching for any disruption)
  • Any digestive discomfort or easy bruising as early warning signs